Altimmune ALT Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's interest expense?
- Altimmune (ALT) reported interest expense of $1.07M in Q1 2026.
- How has Altimmune's interest expense changed year-over-year?
- Altimmune's interest expense increased by 106700.0% year-over-year, from $1K to $1.07M.
- What is the long-term trend for Altimmune's interest expense?
- Over 2 years (2023 to 2025), Altimmune's interest expense has grown at a 583.7% compound annual growth rate (CAGR), from $35K to $1.64M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.